{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:55:25Z","timestamp":1786121725912,"version":"build-2736575974"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004375","name":"Tel Aviv University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004375","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Child Adolesc Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Nonadherence to pharmacological treatment for attention-deficit\/hyperactivity disorder (ADHD) is common among children and adolescents. Despite well-documented clinical and contextual barriers, to the best of our knowledge no dedicated tool exists to quantify parental challenges in supporting adherence. This study aimed to develop and evaluate the\n                    <jats:italic>My Experience with ADHD Pharmacotherapy \u2013 Parent Report (ME WAPH-P)<\/jats:italic>\n                    questionnaire. The ME WAPH-P was developed based on existing instruments, clinical experience, expert input, and literature on nonadherence. The initial 30-item questionnaire assessed adherence-related challenges across six subscales. Parents of children aged 4\u201318 years who had received ADHD medication were recruited via social media and a commercial survey platform. The final sample included 351 parents. Psychometric evaluation included internal consistency, item discrimination, subscale intercorrelations, and exploratory factor analysis (oblique rotation). After removing one item, the 29-item scale demonstrated excellent internal consistency (Cronbach\u2019s \u03b1\u2009=\u20090.90). Subscale reliability demonstrated moderate-to-high intercorrelations. Parallel analysis supported a three-factor structure explaining 44.7% of variance, with moderately correlated factors and some cross-loadings. Parents\u2019 primary concerns focused on adverse effects, doubts about effectiveness and safety, summer treatment breaks, and child resistance. Parents of children treated for less than one year reported significantly higher challenge scores, supporting criterion validity. The current preliminary study supports the potential of the ME WAPH-P in capturing a broad, multidimensional construct of parental challenges in ADHD medication adherence. Findings highlighted child resistance as an underexplored barrier. The dimensionality of the questionnaire construct suggests a cumulative \u201cadherence burden\u201d. This novel tool may support clinical identification and monitoring of adherence challenges with implications for targeted clinical intervention.\n                  <\/jats:p>","DOI":"10.1007\/s00787-026-03148-7","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T06:13:44Z","timestamp":1786083224000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The development and validation of the questionnaire My Experience with ADHD Pharmacotherapy \u2013 Parent Report (ME WAPH-P)"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-6221-4018","authenticated-orcid":false,"given":"Lilac","family":"Mosco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3155-903X","authenticated-orcid":false,"given":"Hagai","family":"Maoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talia","family":"Saker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2729-5422","authenticated-orcid":false,"given":"Nadav","family":"Weisler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuval","family":"Bloch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,7]]},"reference":[{"key":"3148_CR1","doi-asserted-by":"publisher","first-page":"119427","DOI":"10.1016\/j.jad.2025.119427","volume":"388","author":"AF Martin","year":"2025","unstructured":"Martin AF, Rubin GJ, Rogers MB, Wessely S, Greenberg N, Hall CE, Pitt A, Logan PE, Lucas R, Brooks SK (2025) The changing prevalence of ADHD? A systematic review. J Affect Disord 388:119427. https:\/\/doi.org\/10.1016\/j.jad.2025.119427","journal-title":"J Affect Disord"},{"issue":"2","key":"3148_CR2","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s00431-006-0299-5","volume":"166","author":"M Skounti","year":"2007","unstructured":"Skounti M, Philalithis A, Galanakis E (2007) Variations in prevalence of attention deficit hyperactivity disorder worldwide. Eur J Pediatr 166(2):117\u2013123. https:\/\/doi.org\/10.1007\/s00431-006-0299-5","journal-title":"Eur J Pediatr"},{"issue":"1","key":"3148_CR3","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13052-023-01456-1","volume":"49","author":"N Salari","year":"2023","unstructured":"Salari N, Ghasemi H, Abdoli N, Rahmani A, Shiri MH, Hashemian AH, Akbari H, Mohammadi M (2023) The global prevalence of ADHD in children and adolescents: a systematic review and meta-analysis. Ital J Pediatr 49(1):48. https:\/\/doi.org\/10.1186\/s13052-023-01456-1","journal-title":"Ital J Pediatr"},{"issue":"5","key":"3148_CR4","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1097\/00004583-200405000-00009","volume":"43","author":"A Charach","year":"2004","unstructured":"Charach A, Ickowicz A, Schachar R (2004) Stimulant treatment over five years: adherence, effectiveness, and adverse effects. J Am Acad Child Adolesc Psychiatry 43(5):559\u2013567. https:\/\/doi.org\/10.1097\/00004583-200405000-00009","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"9","key":"3148_CR5","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/S2215-0366(18)30269-4","volume":"5","author":"S Cortese","year":"2018","unstructured":"Cortese S, Adamo N, Del Giovane C, Mohr-Jensen C, Hayes AJ, Carucci S et al (2018) Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis. Lancet Psychiatry 5(9):727\u2013738. https:\/\/doi.org\/10.1016\/S2215-0366(18)30269-4","journal-title":"Lancet Psychiatry"},{"key":"3148_CR6","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.2147\/NDT.S65721","volume":"10","author":"K Gajria","year":"2014","unstructured":"Gajria K, Lu M, Sikirica V, Greven P, Zhong Y, Qin P, Xie J (2014) Adherence, persistence, and medication discontinuation in patients with attention-deficit\/hyperactivity disorder - a systematic literature review. Neuropsychiatr Dis Treat 10:1543\u20131569. https:\/\/doi.org\/10.2147\/NDT.S65721","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"6","key":"3148_CR7","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1089\/cap.2012.0022","volume":"22","author":"E Garbe","year":"2012","unstructured":"Garbe E, Mikolajczyk RT, Banaschewski T, Petermann U, Petermann F, Kraut AA, Langner I (2012) Drug treatment patterns of attention-deficit\/hyperactivity disorder in children and adolescents in Germany: results from a large population-based cohort study. J Child Adolesc Psychopharmacol 22(6):452\u2013458","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"3","key":"3148_CR8","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/s00787-024-02538-z","volume":"34","author":"M Ferrin","year":"2025","unstructured":"Ferrin M, H\u00e4ge A, Swanson J, Wong KHTW, Dittmann RW, Banaschewski T, Coghill D, Santosh PJ, Romanos M, Simonoff E, Buitelaar JK, European ADHD Guidelines Group (EAGG) (2025) Medication adherence and persistence in children and adolescents with attention deficit hyperactivity disorder (ADHD): a systematic review and qualitative update. Eur Child Adolesc Psychiatry 34(3):867\u2013882. https:\/\/doi.org\/10.1007\/s00787-024-02538-z","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"1","key":"3148_CR9","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/S2215-0366(23)00332-2","volume":"11","author":"I Brikell","year":"2024","unstructured":"Brikell I, Yao H, Li L et al (2024) ADHD medication discontinuation and persistence across the lifespan: a retrospective observational study using population-based databases. Lancet Psychiatry 11(1):16\u201326. https:\/\/doi.org\/10.1016\/S2215-0366(23)00332-2","journal-title":"Lancet Psychiatry"},{"issue":"12","key":"3148_CR10","doi-asserted-by":"publisher","first-page":"5487","DOI":"10.1007\/s12325-022-02329-5","volume":"39","author":"J Schein","year":"2022","unstructured":"Schein J, Cloutier M, Gauthier-Loiselle M, Bungay R, Guerin A, Childress A (2022) Reasons for treatment changes in children and adolescents with attention-deficit\/hyperactivity disorder: a chart review study. Adv Ther 39(12):5487\u20135503. https:\/\/doi.org\/10.1007\/s12325-022-02329-5","journal-title":"Adv Ther"},{"key":"3148_CR11","unstructured":"Israel Ministry of Health (2021) Criteria for the diagnosis of attention deficit hyperactivity disorder (ADHD) in children, adolescents and adults (Circular No. 15\/2021). Ministry of Health, Medical Division, Jerusalem. https:\/\/www.gov.il\/BlobFolder\/policy\/mr15-2021\/he\/files_circulars_mr_mr15_2021.pdf. Accessed 8 Jul 2026"},{"key":"3148_CR12","unstructured":"Israel Ministry of Health (2020) Pharmacological treatment of attention deficit hyperactivity disorder (ADHD) (Circular No. 4\/2020). Ministry of Health, Medical Division, Jerusalem. https:\/\/www.gov.il\/BlobFolder\/policy\/mr04-2020\/he\/files_circulars_mr_mr04_2020.pdf. Accessed 10 Jul 2026"},{"issue":"4","key":"3148_CR13","doi-asserted-by":"publisher","first-page":"e20192528","DOI":"10.1542\/peds.2019-2528","volume":"144","author":"ML Wolraich","year":"2019","unstructured":"Wolraich ML, Hagan JF Jr, Allan C et al (2019) Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit\/hyperactivity disorder in children and adolescents. Pediatrics 144(4):e20192528. https:\/\/doi.org\/10.1542\/peds.2019-2528","journal-title":"Pediatrics"},{"issue":"1","key":"3148_CR14","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1186\/s12888-023-05090-3","volume":"23","author":"A Shehadeh-Sheeny","year":"2023","unstructured":"Shehadeh-Sheeny A, Baron-Epel O (2023) Prevalence, diagnosis and treatment of ADHD in Arab and Jewish children in Israel, where are the gaps? BMC Psychiatry 23(1):586. https:\/\/doi.org\/10.1186\/s12888-023-05090-3","journal-title":"BMC Psychiatry"},{"issue":"9\u201310","key":"3148_CR15","doi-asserted-by":"publisher","first-page":"e518","DOI":"10.1093\/milmed\/usy161","volume":"183","author":"M Zur","year":"2018","unstructured":"Zur M, Magnezi R, Portuguese S, Reuveni I, Kedem R, Fruchter E (2018) The impact of adherence to treatment for ADHD on the quality of military service - the Israeli military experience. Mil Med 183(9\u201310):e518\u2013e524. https:\/\/doi.org\/10.1093\/milmed\/usy161","journal-title":"Mil Med"},{"issue":"12","key":"3148_CR16","doi-asserted-by":"publisher","first-page":"915","DOI":"10.2165\/00023210-200317120-00005","volume":"17","author":"Y Fogelman","year":"2003","unstructured":"Fogelman Y, Vinker S, Guy N, Kahan E (2003) Prevalence of and change in the prescription of methylphenidate in Israel over a 2-year period. CNS Drugs 17(12):915\u2013919. https:\/\/doi.org\/10.2165\/00023210-200317120-00005","journal-title":"CNS Drugs"},{"issue":"9","key":"3148_CR17","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1177\/0883073808317726","volume":"23","author":"I Berger","year":"2008","unstructured":"Berger I, Dor T, Nevo Y, Goldzweig G (2008) Attitudes toward attention-deficit hyperactivity disorder (ADHD) treatment: parents\u2019 and children\u2019s perspectives. J Child Neurol 23(9):1036\u20131042. https:\/\/doi.org\/10.1177\/0883073808317726","journal-title":"J Child Neurol"},{"issue":"22","key":"3148_CR18","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.2174\/138161210791959908","volume":"16","author":"A Chacko","year":"2010","unstructured":"Chacko A, Newcorn J, Feirsen N, Uderman JZ (2010) Improving medication adherence in chronic pediatric health conditions: a focus on ADHD in youth. Curr Pharm Des 16(22):2416\u20132423","journal-title":"Curr Pharm Des"},{"key":"3148_CR19","doi-asserted-by":"publisher","DOI":"10.1177\/10870547251387006","author":"M Karimi","year":"2025","unstructured":"Karimi M, Ghasemzadeh S, Shabanali Fami F (2025) Treatment adherence in ADHD: a systematic review of influencing factors and strategies for improvement. J Atten Disord. https:\/\/doi.org\/10.1177\/10870547251387006","journal-title":"J Atten Disord"},{"issue":"3","key":"3148_CR20","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1177\/0009922819900973","volume":"59","author":"MU Khan","year":"2020","unstructured":"Khan MU, Aslani P (2020) Exploring factors influencing medication adherence from initiation to discontinuation in parents and adolescents with attention deficit hyperactivity disorder. Clin Pediatr (Phila) 59(3):285\u2013296","journal-title":"Clin Pediatr (Phila)"},{"issue":"2","key":"3148_CR21","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1177\/1087054713499231","volume":"21","author":"R Ahmed","year":"2017","unstructured":"Ahmed R, Borst J, Wei YC, Aslani P (2017) Parents\u2019 perspectives about factors influencing adherence to pharmacotherapy for ADHD. J Atten Disord 21(2):91\u201399. https:\/\/doi.org\/10.1177\/1087054713499231","journal-title":"J Atten Disord"},{"issue":"2","key":"3148_CR22","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1093\/fampra\/cmx088","volume":"35","author":"MA Rashid","year":"2018","unstructured":"Rashid MA, Lovick S, Llanwarne NR (2018) Medication-taking experiences in attention deficit hyperactivity disorder: a systematic review. Fam Pract 35(2):142\u2013150. https:\/\/doi.org\/10.1093\/fampra\/cmx088","journal-title":"Fam Pract"},{"issue":"8","key":"3148_CR23","first-page":"25","volume":"18","author":"KI Kamimura-Nishimura","year":"2019","unstructured":"Kamimura-Nishimura KI, Brinkman WB, Froehlich TE (2019) Strategies for improving ADHD medication adherence. Curr Psychiatry 18(8):25\u201338","journal-title":"Curr Psychiatry"},{"issue":"3","key":"3148_CR24","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1177\/1534650107307476","volume":"7","author":"D Reitman","year":"2008","unstructured":"Reitman D, Passeri C (2008) Use of stimulus fading and functional assessment to treat pill refusal with an 8-year-old boy diagnosed with ADHD. Clin Case Stud 7(3):224\u2013237","journal-title":"Clin Case Stud"},{"issue":"5","key":"3148_CR25","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1089\/cap.2008.023","volume":"18","author":"RA Harpur","year":"2008","unstructured":"Harpur RA, Thompson M, Daley D, Abikoff H, Sonuga-Barke EJ (2008) The attention-deficit\/hyperactivity disorder medication-related attitudes of patients and their parents. J Child Adolesc Psychopharmacol 18(5):461\u2013473","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"3","key":"3148_CR26","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.acap.2017.09.005","volume":"18","author":"WB Brinkman","year":"2018","unstructured":"Brinkman WB, Simon JO, Epstein JN (2018) Reasons why children and adolescents with attention-deficit\/hyperactivity disorder stop and restart taking medicine. Acad Pediatr 18(3):273\u2013280. https:\/\/doi.org\/10.1016\/j.acap.2017.09.005","journal-title":"Acad Pediatr"},{"issue":"1","key":"3148_CR27","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1521\/adhd.10.1.6.20567","volume":"10","author":"C Johnston","year":"2002","unstructured":"Johnston C, Freeman W (2002) Parents\u2019 beliefs about ADHD: implications for assessment and treatment. ADHD Rep 10(1):6\u20139","journal-title":"ADHD Rep"},{"issue":"7","key":"3148_CR28","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1177\/1087054714548035","volume":"19","author":"K Ibrahim","year":"2015","unstructured":"Ibrahim K, Donyai P (2015) Drug holidays from ADHD medication: international experience over the past four decades. J Atten Disord 19(7):551\u2013568. https:\/\/doi.org\/10.1177\/1087054714548035","journal-title":"J Atten Disord"},{"issue":"12","key":"3148_CR29","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.5498\/wjp.v11.i12.1206","volume":"11","author":"R Baweja","year":"2021","unstructured":"Baweja R, Soutullo CA, Waxmonsky JG (2021) Review of barriers and interventions to promote treatment engagement for pediatric attention deficit hyperactivity disorder care. World J Psychiatry 11(12):1206\u20131227","journal-title":"World J Psychiatry"},{"issue":"8","key":"3148_CR30","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1177\/0269881120908014","volume":"34","author":"R Fried","year":"2020","unstructured":"Fried R, DiSalvo M, Kelberman C, Adler A, McCafferty D, Woodworth KY, Green A, Biederman I, Faraone SV, Biederman J (2020) An innovative SMS intervention to improve adherence to stimulants in children with ADHD: preliminary findings. J Psychopharmacol 34(8):883\u2013890","journal-title":"J Psychopharmacol"},{"issue":"8","key":"3148_CR31","doi-asserted-by":"publisher","first-page":"e295","DOI":"10.2196\/jmir.7740","volume":"19","author":"AL Rathbone","year":"2017","unstructured":"Rathbone AL, Prescott J (2017) The use of mobile apps and SMS messaging as physical and mental health interventions: systematic review. J Med Internet Res 19(8):e295. https:\/\/doi.org\/10.2196\/jmir.7740","journal-title":"J Med Internet Res"},{"key":"3148_CR32","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.jpsychires.2022.05.044","volume":"152","author":"R Parkin","year":"2022","unstructured":"Parkin R, Mc Nicholas F, Hayden JC (2022) A systematic review of interventions to enhance adherence and persistence with ADHD pharmacotherapy. J Psychiatr Res 152:201\u2013218","journal-title":"J Psychiatr Res"},{"issue":"6","key":"3148_CR33","doi-asserted-by":"publisher","first-page":"e20172580","DOI":"10.1542\/peds.2017-2580","volume":"141","author":"WB Brinkman","year":"2018","unstructured":"Brinkman WB, Sucharew H, Majcher JH, Epstein JN (2018) Predictors of medication continuity in children with ADHD. Pediatrics 141(6):e20172580. https:\/\/doi.org\/10.1542\/peds.2017-2580","journal-title":"Pediatrics"},{"issue":"4","key":"3148_CR34","first-page":"317","volume":"22","author":"J H\u00e9bert","year":"2013","unstructured":"H\u00e9bert J, Polotskaia A, Joober R, Grizenko N (2013) Adherence to psychostimulant medication in children with attention-deficit\/hyperactivity disorder: the role of attitudes. J Can Acad Child Adolesc Psychiatry 22(4):317\u2013323","journal-title":"J Can Acad Child Adolesc Psychiatry"},{"issue":"10","key":"3148_CR35","doi-asserted-by":"publisher","first-page":"401","DOI":"10.3390\/bs12100401","volume":"12","author":"A Caqueo-Ur\u00edzar","year":"2022","unstructured":"Caqueo-Ur\u00edzar A, Urz\u00faa A, Villalonga-Olives E, Atencio-Quevedo D, Irarr\u00e1zaval M, Flores J, Ram\u00edrez C (2022) Children\u2019s mental health: discrepancy between child self-reporting and parental reporting. Behav Sci (Basel) 12(10):401. https:\/\/doi.org\/10.3390\/bs12100401","journal-title":"Behav Sci (Basel)"},{"issue":"6","key":"3148_CR36","doi-asserted-by":"publisher","first-page":"e0178863","DOI":"10.1371\/journal.pone.0178863","volume":"12","author":"YY Chen","year":"2017","unstructured":"Chen YY, Ho SY, Lee PC, Wu CK, Gau SS (2017) Parent-child discrepancies in the report of adolescent emotional and behavioral problems in Taiwan. PLoS ONE 12(6):e0178863. https:\/\/doi.org\/10.1371\/journal.pone.0178863","journal-title":"PLoS ONE"},{"key":"3148_CR37","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/1471-244X-12-87","volume":"12","author":"L Thompson","year":"2012","unstructured":"Thompson L, McCabe R (2012) The effect of clinician-patient alliance and communication on treatment adherence in mental health care: a systematic review. BMC Psychiatry 12:87. https:\/\/doi.org\/10.1186\/1471-244X-12-87","journal-title":"BMC Psychiatry"},{"key":"3148_CR38","doi-asserted-by":"publisher","first-page":"117576","DOI":"10.1016\/j.socscimed.2024.117576","volume":"365","author":"ME Heffernan","year":"2025","unstructured":"Heffernan ME, Alfieri NL, Keese A et al (2025) Differences in responsibility for child healthcare by parent gender: a cross-sectional study. Soc Sci Med 365:117576. https:\/\/doi.org\/10.1016\/j.socscimed.2024.117576","journal-title":"Soc Sci Med"},{"issue":"4","key":"3148_CR39","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1177\/10870547231215518","volume":"28","author":"K Lewczuk","year":"2024","unstructured":"Lewczuk K, Marcowski P, Wiz\u0142a M et al (2024) Cross-cultural adult ADHD assessment in 42 countries using the Adult ADHD Self-Report Scale Screener. J Atten Disord 28(4):512\u2013530. https:\/\/doi.org\/10.1177\/10870547231215518","journal-title":"J Atten Disord"}],"container-title":["European Child &amp; Adolescent Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00787-026-03148-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00787-026-03148-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00787-026-03148-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T06:13:46Z","timestamp":1786083226000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00787-026-03148-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,7]]},"references-count":39,"alternative-id":["3148"],"URL":"https:\/\/doi.org\/10.1007\/s00787-026-03148-7","relation":{},"ISSN":["1018-8827","1435-165X"],"issn-type":[{"value":"1018-8827","type":"print"},{"value":"1435-165X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,7]]},"assertion":[{"value":"23 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approvals were given by the Shalvata Hospital IRB (0021-23-SHA), and by the Tel Aviv University Ethical Committee (0008337-1).","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}